Anyway, blind people with Non-24 are likely not the primary target of the company’s ads. As Dr. Czeisler noted at the approval meeting, disturbed circadian sleep cycles—aka jet lag—are a huge problem for frequent fliers and that is a much bigger target market. By 2016 the company was conducting trials for that indication. Once a drug is approved for one use, doctors can prescribe it for others, as they see fit. Vanda is endeavoring to expand the boundaries. The things Vanda says you should consider before “talking to your doctor about whether Hetlioz is right for you” are as general as “I have
...more
